Genor Biopharma Holdings Ltdalso Known As Genor Biopharma Co Ltd Is A Biopharmaceutical Company Based In Shanghaichinafounded In 2017The Company Focuses On The Discoverydevelopmentand Commercialization Of Biopharmaceutical Products For Human Useits Product Pipeline Includes Gb491Lerociclib Gb261And Gb263Twhich Target Various Diseases Such As Breast Cancerlung Cancergastrointestinal Tumorsand Blood Tumors Genor Biopharma Is Dedicated To Extensive Research And Development To Advance Its Offerings In The Biopharmaceutical Sectorthe Company Primarily Serves The Domestic Market In Chinatargeting Healthcare Providers And Patients In Need Of Innovative Treatmentsas Of The Latest Datagenor Biopharma Reported A Revenue Of Approximately Hkd 15 49 Millionwith A Workforce Of About 28 Employeesin October 2024The Company Announced A Significant Acquisition Of Edding Group Co Ltdvalued At Approximately Hkd 386 97 Million
